IP Library Patent Application 12720054
Patent Application
App. No. 12/720,054

Terminus-Specific DNA Modification Using Random-Sequence Template Oligonucleotides

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/720,054
Abstract

A method is provided for analyzing DNA molecules having unknown 3′ terminal sequences. The method involves contacting a DNA molecule with a plurality of template oligonucleotides blocked at their 3′ termini such that the template oligonucleotides are not extendable by DNA polymerase. The 3′ proximal portions of each of the template oligonucleotides comprise a region of random sequence and the 5′ proximal portions of each of the template oligonucleotides comprise the complement of a tag sequence. The DNA molecule and the template oligonucleotides are combined under conditions wherein the 3′ terminus of the DNA molecule hybridizes to the 3′ proximal portion of a template oligonucleotide and is extended by a DNA polymerase to produce a DNA molecule comprising a 3′ terminal tag sequence, and wherein the template oligonucleotide is not extended.

Claims (16)

1 - 20 . (canceled)

21 . A method of analyzing a DNA molecule having an unknown 3′ terminal sequence, comprising:

a) providing a sample comprising at least one DNA molecule having a 3′ terminus of unknown sequence;

b) combining said sample with a mixture comprising a plurality of template oligonucleotides blocked at their 3′ termini such that said plurality of template oligonucleotides are not extendable by a DNA- or RNA-directed DNA polymerase, wherein 3′ proximal portions of said plurality of template oligonucleotides each comprise a region of random sequence and wherein 5′ proximal portions of said plurality of template oligonucleotides each comprise the complement of a tag sequence, and under conditions wherein:

i) said 3′ terminus of said DNA molecule hybridizes to the 3′ proximal portion of a template oligonucleotide, and

ii) said 3′ terminus of said DNA molecule is extended by a DNA- or RNA-directed DNA polymerase to produce a DNA molecule comprising a 3′ terminal tag sequence, and

iii) said template oligonucleotide is not extended by said DNA- or RNA-directed DNA polymerase; and

c) detecting said DNA comprising said 3′ terminal tag sequence.

22 . The method of claim 21 , wherein said detecting comprises amplification.

23 . The method of claim 21 , wherein said detecting comprises sequencing.

24 . The method of claim 21 , wherein said detecting comprises hybridizing said nucleic acid comprising said 3′ terminal tag sequence to an oligonucleotide primer, said primer complementary to at least a portion of said 3′ terminal tag sequence.

25 . The method of claim 21 , further comprising a step of separating said DNA molecule comprising a 3′ terminal tag sequence and said template oligonucleotide.

26 . The method of claim 21 , further comprising a step of purifying said DNA molecule comprising a 3′ terminal tag sequence from said plurality of template oligonucleotides.

27 . The method of claim 22 , wherein said amplification comprises PCR.

28 . The method of claim 21 , wherein said polymerase comprises a DNA-directed DNA polymerase.

29 . The method of claim 21 , wherein said polymerase comprises a reverse transcriptase.

Assignments (5)
CHANGE OF NAME Recorded Apr 14, 2011
From: CELLSCRIPT, LLC
To: CELLSCRIPT, INC.
Reel/Frame 026131/0423 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2011
From: ALETHIA BIOTHERAPEUTICS
To: EPICENTRE TECHNOLOGIES CORPORATION
Reel/Frame 025778/0155 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CHAIN OF TITLE PREVIOUSLY RECORDED ON REEL 024807 FRAME 0361. ASSIGNOR(S) HEREBY CONFIRMS THE INVENTOR ASSIGNED TO ALETHIA BIOTHERAPEUTICS, INC.. Recorded Nov 5, 2010
From: SOOKNANAN, ROY RABINDRANAUTH
To: ALETHIA BIOTHERAPEUTICS, INC.
Reel/Frame 025313/0932 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CHAIN OF TITLE PREVIOUSLY RECORDED ON REEL 024807 FRAME 0361. ASSIGNOR(S) HEREBY CONFIRMS THE INVENTOR DIDN'T ASSIGN DIRECTLY TO EPICENTRE, BUT INVENTOR ASSIGNED TO ALETHIA, THEN ALETHIA ASSIGNED TO EPICENTRE. Recorded Aug 27, 2010
From: SOOKNANAN, ROY RABINDRANAUTH; ALETHIA BIOTHERAPEUTICS, INC.
To: EPICENTRE TECHNOLOGIES CORPORATION
Reel/Frame 024901/0911 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2010
From: SOOKNANAN, ROY RABINDRANAUTH
To: EPICENTRE TECHNOLOGIES CORPORATION
Reel/Frame 024807/0361 →